Have a personal or library account? Click to login
Aortic Valve Sclerosis and Degenerative Valve Disease in a Nigerian Population: An Echocardiographic Study Cover

Aortic Valve Sclerosis and Degenerative Valve Disease in a Nigerian Population: An Echocardiographic Study

Global Heart
Volume 20 (2025): Issue 1
By: Olugbenga O. Abiodun,  Ibrahim L. Salau and  Tina Anya  
Open Access
|Aug 2025

References

  1. 1Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, et al. Global Burden of Disease Study 2017 Nonrheumatic Valve Disease Collaborators. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990–2017. Circulation. 2020;141(21):1670–1680. DOI: 10.1161/CIRCULATIONAHA.119.043391
    Back to article
  2. 2Liu Z, Wei P, Jiang H, Zhang F, Ouyang W, Wang S, et al. Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019. International Journal of Cardiology. 2024;395:131561. DOI: 10.1016/j.ijcard.2023.131561
    Back to article
  3. 3Ancona R, Pinto SC. Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI): is the prevalence of AS/AI similar in different parts of the world? e-Journal of Cardiology Practice. 2020;18:10–12.
    Back to article
  4. 4Yutzey KE, Demer LL, Body SC, Huggins GS, Towler DA, Giachelli CM, et al. Calcific aortic valve disease: A consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;34(11):2387–2393. DOI: 10.1161/ATVBAHA.114.302523
    Back to article
  5. 5Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: The Cardiovascular Health Study. Journal of the American College of Cardiology. 2007;50(20):1992–1998. DOI: 10.1016/j.jacc.2007.07.064
    Back to article
  6. 6Owens DS, Katz R, Takasu J, Kronmal R, Budoff MJ, O’Brien KD. Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis (MESA). American Journal of Cardiology. 2010;105(5):701–708. DOI: 10.1016/j.amjcard.2009.10.071
    Back to article
  7. 7Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, ASTRONOMER Investigators. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: Results of the aortic stenosis progression observation: Measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306–314. DOI: 10.1161/CIRCULATIONAHA.109.900027
    Back to article
  8. 8Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al., SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. The New England Journal of Medicine. 2008;359(13):1343–1356. DOI: 10.1056/NEJMoa0804602
    Back to article
  9. 9Tibbutt DA. Valvular heart disease is changing: A challenge for Africa. South Sudan Medical Journal. 2015;8(4):86–89.
    Back to article
  10. 10Ogah OS, Bode-Thomas F, Yilgwan C, Sani MU. Rheumatic heart disease in Nigeria: A review. Nigerian Journal of Cardiology. 2020;17(1):27. DOI: 10.4103/njc.njc_30_19
    Back to article
  11. 11Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al., Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of American Society of Echocardiography. 2005;18(12):1440–1463. DOI: 10.1016/j.echo.2005.10.005
    Back to article
  12. 12GBD 2015 Obesity Collaborators; Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of overweight and obesity in 195 countries over 25 years. The New England Journal of Medicine. 2017;377(1):13–27. DOI: 10.1056/NEJMoa1614362
    Back to article
  13. 13Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of American Society of Echocardiography. 2015;28(1):1–39.e14. DOI: 10.1016/j.echo.2014.10.003
    Back to article
  14. 14Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). Journal of Hypertension. 2023; 41(12):1874–2071. DOI: 10.1097/HJH.0000000000003480
    Back to article
  15. 15American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–S28. DOI: 10.2337/dc19-S002
    Back to article
  16. 16Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al., ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407–477. DOI: 10.1093/eurheartj/ehz425
    Back to article
  17. 17Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467. DOI: 10.1161/STR.0000000000000375
    Back to article
  18. 18Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd., Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021;77(4):e25–e197. DOI: 10.1016/j.jacc.2020.11.018
    Back to article
  19. 19Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS guidelines for the management of valvular heart disease. European Heart Journal. 2022;43(7):561–632. DOI: 10.1093/eurheartj/ehab395
    Back to article
  20. 20Coffey S, Cox B, Williams MJ. The prevalence, incidence, progression, and risks of aortic valve sclerosis: A systematic review and meta-analysis. Journal of the American College of Cardiology. 2014;63(25 pt. A):2852–2861. DOI: 10.1016/j.jacc.2014.04.018
    Back to article
  21. 21Agno FS, Chinali M, Bella JN, Liu JE, Arnett DK, Kitzman DW, et al. Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: The Hypertension Genetic Epidemiology Network study. Journal of Hypertension. 2005;23(4):867–873. DOI: 10.1097/01.hjh.0000163157.14493.c7
    Back to article
  22. 22Prasad Y, Bhalodkar NC. Aortic sclerosis: A marker of coronary atherosclerosis. Clinical Cardiology. 2004;27(12):671–673. DOI: 10.1002/clc.4960271202
    Back to article
  23. 23Nightingale AK, Horowitz JD. Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart. 2005;91(11):1389–1393. DOI: 10.1136/hrt.2004.057117
    Back to article
  24. 24Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. The New England Journal of Medicine. 1999;341(3):142–147. DOI: 10.1056/NEJM199907153410302
    Back to article
  25. 25Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: The Cardiovascular Health Study. Journal of the American College of Cardiology. 2007;50(20):1992–1998. DOI: 10.1016/j.jacc.2007.07.064
    Back to article
  26. 26Ferreira-González I, Pinar-Sopena J, Ribera A, Marsal JR, Cascant P, González-Alujas T, et al. Prevalence of calcific aortic valve disease in the elderly and associated risk factors: A population-based study in a Mediterranean area. European Journal of Preventive Cardiology. 2013;20(6):1022–1030. DOI: 10.1177/2047487312451238
    Back to article
  27. 27Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: A population-based study. Lancet. 2006;368(9540):1005–1011. DOI: 10.1016/S0140-6736(06)69208-8
    Back to article
  28. 28World Health Organization. data.who.int, Nigeria [Country overview] 2025. (Accessed on 12 March 2025).
    Back to article
  29. 29Elmariah S, Delaney JA, Bluemke DA, Budoff MJ, O’Brien KD, Fuster V, et al. Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-ethnic study of atherosclerosis. JACC: Cardiovascular Imaging. 2012;5(8):781–788. DOI: 10.1016/j.jcmg.2011.12.025
    Back to article
  30. 30Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS guidelines for the management of valvular heart disease. European Heart Journal. 2022;43(7):561–632. DOI: 10.1093/eurheartj/ehab395
    Back to article
DOI: https://doi.org/10.5334/gh.1455 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Mar 16, 2025
Accepted on: Jul 24, 2025
Published on: Aug 19, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
aortic sclerosis,
calcific aortic valve disease,
degenerative mitral valve disease,
degenerative valve disease,
non-rheumatic valve disease,
Nigeria

© 2025 Olugbenga O. Abiodun, Ibrahim L. Salau, Tina Anya, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 20 (2025): Issue 1Next article